Replies to post #41944 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

If PolyM had revenue streams I would say no added risk, but since it does not have any revenue that means products have to be commercialized and that takes money so, as staunch a backer as I am of the acquisition of PolyM and cancellation of PoC, even I realize there is added risk.